Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Drug Discovery and Pharmaceutical Research			631.80M	735.24M	612.97M	354.98M	252.94M
Drug Discovery and Pharmaceutical Research Growth			-14.07%	19.95%	72.68%	40.34%	39.50%
Preclinical Study			733.80M	923.63M	553.53M	310.64M	195.75M
Preclinical Study Growth			-20.55%	66.86%	78.19%	58.69%	36.29%
Total			1.37B	1.66B	1.17B	665.62M	448.68M
Total Growth			-17.68%	42.21%	75.25%	48.35%	38.08%

Source: S&P Global Market Intelligence.